Funding Nottingham University Hospitals NHS Trust sponsors the trial and provides the necessary trial insurance. The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (project number 12/35/38).Peer reviewedPublisher PD
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Objective: To determine whether primary trabeculectomy or primary medical treatment produces better ...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
BACKGROUND: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
OBJECTIVE: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
Synopsis: Advanced glaucoma is associated with sight loss. This within-trial economic evaluation com...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
Funding Information: This work was supported by the National Institute for Health Research Health Te...
Synopsis Advanced glaucoma is associated with sight loss. This within-trial economic evaluation comp...
Funding Information: This work was supported by the National Institute for Health Research Health Te...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Objective: To determine whether primary trabeculectomy or primary medical treatment produces better ...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
The trial is funded by a grant awarded by the Health Technology Assessment (NIHR HTA) programme (pro...
BACKGROUND: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
Background: Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Eff...
OBJECTIVE: To determine whether primary trabeculectomy or primary medical treatment produces better ...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
Synopsis: Advanced glaucoma is associated with sight loss. This within-trial economic evaluation com...
Funding: The project was funded by the National Institute of Health Research (NIHR) Health Technolog...
Funding Information: This work was supported by the National Institute for Health Research Health Te...
Synopsis Advanced glaucoma is associated with sight loss. This within-trial economic evaluation comp...
Funding Information: This work was supported by the National Institute for Health Research Health Te...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Background: Patients diagnosed with advanced primary open-angle glaucoma are at a high risk of lifet...
Objective: To determine whether primary trabeculectomy or primary medical treatment produces better ...